Skip to main content
Equibles

RPGLIFE · RPG Life Sciences Limited

Use RPGLIFE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RPGLIFE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,551.45 INR -27.55 (-1.07%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 386 Avg daily vol (3M) 1353

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close2,551.45 INR Open2,571.65 INR Day2,529.15–2,611.00 INR 52W close1,733.80–3,090.1001 INR Avg vol 30d1K Last earningsOct 30, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Oct 30
Earnings call
Revenue tops 200 crore as adjusted EBITDA reaches 50.1 crore

RPG Life Sciences Limited reported quarterly revenue above 200 crore and adjusted EBITDA of 50.1 crore; H1 revenue reached 407.3 crore, up 16.2%, while completing API acquisitions.

5 source passages
RPG Life Sciences has a legacy for more than five decades. For the first time, we crossed 200 crore in quarterly revenue and 50 crore in quarterly EBITDA. With our adjusted EBITDA, excluding one-time restructuring and API acquisition link cost of 5.5 crore, we grew 15% to 50.1 crore in quarter two versus 43.6 crore last year. For the first half, revenue growth grew 16.2% to 407.3, crossing the 400 crore mark for a half year. All three of our business grew, and in parallel, we completed the most significant strategic step in the history of our API business with the creation of RPG Active Pharma and the acquisitions of Actives and Ragwa. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
· 1.80B INR 0 INR '26 Q3 · 1.77B INR 299.00M INR '26 Q4 · 1.96B INR 0 INR '27 Q1 LATEST · 2.12B INR 266.00M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 1,733.80 INR Now 2,551.45 INR · 60% Range high 3,090.1001 INR
vs 200-day avg +7% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:RPGLIFE -0.2% -7.8% +11.0% -0.8% +10.0%

Exchange listing

Market
XBOM
Ticker
RPGLIFE
ISIN
INE105J01010
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.rpglifesciences.com/
Investor relations
https://www.rpglifesciences.com/website/code_policies_forms.php

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-07-09 24.00 INR
2025-06-27 24.00 INR
2024-06-28 16.00 INR
2023-07-21 12.00 INR
2022-07-14 9.60 INR
2021-08-13 7.20 INR
2020-03-24 4.00 INR
2019-07-22 2.40 INR
2018-07-19 2.40 INR
2016-03-22 1.60 INR
2015-07-20 0.80 INR
2013-07-11 1.20 INR
2012-07-24 0.80 INR
2011-07-14 1.60 INR
2010-07-15 1.44 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-30 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q4 2026 2026-04-30
    Earnings Call for the Quarter Ended March 31, 2026